Works about LEUCOPENIA

Results: 812
    1

    Your Medication Information.

    Published in:
    Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 9, doi. 10.1002/pu.30945
    Publication type:
    Article
    2

    Paliperidone Invega.

    Published in:
    Brown University Psychopharmacology Update, 2015, v. 26, p. 1
    Publication type:
    Article
    3

    Ziprasidone Geodon.

    Published in:
    Brown University Psychopharmacology Update, 2014, v. 25, p. 1
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.

    Published in:
    Oncology, 2018, v. 94, n. 4, p. 207, doi. 10.1159/000486038
    By:
    • Igawa, Satoshi;
    • Shirasawa, Masayuki;
    • Fukui, Tomoya;
    • Nishinarita, Noriko;
    • Sone, Hideyuki;
    • Ozawa, Takahiro;
    • Sugita, Keisuke;
    • Okuma, Yuriko;
    • Kurahayashi, Shintaro;
    • Ono, Taihei;
    • Sugimoto, Ai;
    • Mitsufuji, Hisashi;
    • Kubota, Masaru;
    • Katagiri, Masato;
    • Sasaki, Jiichiro;
    • Naoki, Katsuhiko
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    A review of select minerals influencing the haematopoietic process.

    Published in:
    Nutrition Research Reviews, 2018, v. 31, n. 2, p. 267, doi. 10.1017/S0954422418000112
    By:
    • Oliveira, Dalila Cunha;
    • Nogueira-Pedro, Amanda;
    • Santos, Ed Wilson;
    • Hastreiter, Araceli;
    • Silva, Graziela Batista;
    • Borelli, Primavera;
    • Fock, Ricardo Ambrósio
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.

    Published in:
    Oncologist, 2023, v. 28, n. 1, p. 23, doi. 10.1093/oncolo/oyac205
    By:
    • Cosimo, Serena Di;
    • Pérez-García, José Manuel;
    • Bellet, Meritxell;
    • Dalenc, Florence;
    • Gil, Miguel J Gil;
    • Borrego, Manuel Ruiz;
    • Gavilá, Joaquín;
    • Sampayo-Cordero, Miguel;
    • Aguirre, Elena;
    • Schmid, Peter;
    • Marmé, Frederik;
    • Gligorov, Joseph;
    • Schneeweiss, Andreas;
    • Albanell, Joan;
    • Zamora, Pilar;
    • Wheatley, Duncan;
    • Dueñas, Eduardo Martínez-De;
    • Carañana, Vicente;
    • Amillano, Kepa;
    • Mina, Leonardo
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer.

    Published in:
    Oncologist, 2021, v. 26, n. 3, p. e382, doi. 10.1002/onco.13574
    By:
    • Yuan, Yuan;
    • Lee, Jin Sun;
    • Yost, Susan E.;
    • Li, Sierra Min;
    • Frankel, Paul H.;
    • Ruel, Christopher;
    • Schmolze, Daniel;
    • Robinson, Kim;
    • Tang, Aileen;
    • Martinez, Norma;
    • Stewart, Daphne;
    • Waisman, James;
    • Kruper, Laura;
    • Jones, Veronica;
    • Menicucci, Andrea;
    • Uygun, Sahra;
    • Yoder, Erin;
    • Baan, Bastiaan;
    • Yim, John H.;
    • Yeon, Christina
    Publication type:
    Article
    37

    Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).

    Published in:
    Oncologist, 2020, v. 25, n. 12, p. e1855, doi. 10.1634/theoncologist.2020-0643
    By:
    • Satake, Hironaga;
    • Kato, Takeshi;
    • Oba, Koji;
    • Kotaka, Masahito;
    • Kagawa, Yoshinori;
    • Yasui, Hisateru;
    • Nakamura, Masato;
    • Watanabe, Takanori;
    • Matsumoto, Toshihiko;
    • Kii, Takayuki;
    • Terazawa, Tetsuji;
    • Makiyama, Akitaka;
    • Takano, Nao;
    • Yokota, Mitsuru;
    • Okita, Yoshihiro;
    • Matoba, Koreatsu;
    • Hasegawa, Hiroko;
    • Tsuji, Akihito;
    • Komatsu, Yoshito;
    • Yoshino, Takayuki
    Publication type:
    Article
    38

    Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)

    Published in:
    Oncologist, 2020, v. 25, n. 5, p. e798, doi. 10.1634/theoncologist.2019-0437
    By:
    • Chakravarthy, A. Bapsi;
    • Zhao, Fengmin;
    • Meropol, Neal J.;
    • Flynn, Patrick J.;
    • Wagner, Lynne I.;
    • Sloan, Jeffrey;
    • Diasio, Robert B.;
    • Mitchell, Edith P.;
    • Catalano, Paul;
    • Giantonio, Bruce J.;
    • Catalano, Robert B.;
    • Haller, Daniel G.;
    • Awan, Rashid A.;
    • Mulcahy, Mary F.;
    • O'Brien, Timothy E.;
    • Santala, Roger;
    • Cripps, Christine;
    • Weis, John R.;
    • Atkins, James N.;
    • Leichman, Cynthia G.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50